Live Breaking News & Updates on Precision diagnostics

Stay informed with the latest breaking news from Precision diagnostics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Precision diagnostics and stay connected to the pulse of your community

Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results

Full Year 2023 Total Revenue of $289.2 million; Q4 2023 Total Revenue of $70.5 million



Full Year 2023 Core Revenue grows 44% year-over-year to $262.1 million; Q4 2023 Core Revenue grows 21%...

United-states , America , Paul-kim , Ming-hsieh , Fulgent-genetics-inc , Nasdaq , Exchange-commission , Fulgent-genetics , Core-revenue , Chief-executive-officer , Precision-diagnostics , Investigational-new-drug

Following Up On Fulgent Genetics (NASDAQ:FLGT)

Following Up On Fulgent Genetics (NASDAQ:FLGT)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Piper-sandler , Albert-einstein , Covid-cliff , Los-angeles , Fulgent-genetics-inc , Company-overview , Nasdaq , Fulgent-genetics , Covid-cliff- , Quarter-results , Precision-diagnostics , Balance-sheet

Myriad Genetics (MYGN) and QIAGEN (QGEN) partner over diagnostics development for cancer

Myriad Genetics (MYGN) and QIAGEN (QGEN) partner over diagnostics development for cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jonathan-arnold , Paul-bartel , Myriad-genetics , Vice-president , Translational-science , Precision-diagnostics , Senior-vice-president , Companion-diagnostics ,

QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer

26.10.2023 - Partnership covers development of lab-developed and distributable kit-based companion diagnostic testsCombined strengths in assay development, clinical testing, and regulatory approvals offers pharma partners comprehensive global companion ... Seite 1

Jonathan-arnold , Vice-president , Translational-science , Precision-diagnostics , Myriad-genetics-chart , Yriad-genetics-kurs , Yriad-genetics-aktie ,